Baihua Pharmaceuticals: Wholly owned subsidiary acquires a 4.75% stake in Nantong Qinjian Jianteng Fund

Every Daily AI News, on March 27, Baihua Pharmaceutical announced that its wholly-owned subsidiary, Nanjing Baihua Xinseng Biomedical Technology Co., Ltd., acquired a 4.75% stake in Nantong Qinzhi Jianteng Venture Capital Partnership (Limited Partnership) from Jiangsu Jinzhu Commercial Service Co., Ltd. at no premium, corresponding to a subscribed capital contribution of 9.5 million yuan, of which the first phase of the paid-in capital contribution of 2.85 million yuan has been completed.

Daily Economic News

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin